Emdeon to Present at the Credit Suisse Health Care Conference

* Reuters is not responsible for the content in this press release.

Thu Oct 29, 2009 8:31am EDT

NASHVILLE, Tenn., Oct. 29 /PRNewswire-FirstCall/ -- Emdeon (NYSE: EM), a
leading provider of healthcare revenue and payment cycle management solutions,
today announced that it will make a presentation to attendees at the Credit
Suisse Health Care Conference to be held from November 11 to 13, 2009 in
Phoenix, Arizona. 

The presentation by George Lazenby, Chief Executive Officer, will begin at
2:00 p.m. Eastern time/12:00 p.m. Phoenix time on Thursday, November 12, 2009.
A live audio webcast of the presentation and a copy of the slides accompanying
the presentation will be available in the Investors section of Emdeon's
website at www.emdeon.com. Please go to the website at least 15 minutes prior
to the event to register, download and install any necessary audio/video
software to access the presentation. For those unable to participate in the
live webcast, a replay of the presentation and a copy of the presentation
slides will be archived on the Investors section of Emdeon's website for at
least 30 days following the conference. 

About Emdeon 

Emdeon (NYSE: EM) is a leading provider of revenue and payment cycle
management solutions, connecting payers, providers and patients in the U.S.
healthcare system. Emdeon's product and service offerings integrate and
automate key business and administrative functions of its payer and provider
customers throughout the patient encounter. Through the use of Emdeon's
comprehensive suite of products and services, which are designed to easily
integrate with existing technology infrastructures, customers are able to
improve efficiency, reduce costs, increase cash flow and more efficiently
manage the complex revenue and payment cycle process. For more information,
visit www.emdeon.com. 


SOURCE  Emdeon

Investor Relations: Tommy Lewis of Emdeon, +1-615-932-3235, tlewis@emdeon.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.